Monday, June 19, 2017 10:18:30 AM
"After researching options for an affordable, Windows-compatible fingerprint reader, BIO-key's compact readers, which are tested and qualified by Microsoft, stood out as the most compelling solution," stated Kenji Miyoshino, President & CEO, DDS. "We chose SideSwipe because of its performance capabilities, native integration with Windows and its ability to support DDS solution packages. SideSwipe works well with DDS's "EVE MA" solution, which offers flexible multifactor authentication options including ID Card and fingerprint, as well as our "EVE FA" solution for large scale ID programs with authentication taking place on the server."
"We are excited to announce DDS as a major OEM customer in Japan," stated Wong Kwok Fong, Managing Director, BIO-key Hong Kong Limited. "SideSwipe was designed to deliver fast and accurate fingerprint authentication with the ability to support any Windows 7, 8.1 or 10 device. We look forward to working closely with DDS to support their customer deployments and look to expand our relationship to other BIO-key fingerprint solutions, such as our new SidePass reader, in the future," added Wong.
About DDS (http://en.dds.co.jp/)
Traded on the Tokyo Stock Exchange (symbol: 3782:JP), DDS Inc. is engaged in the research and development of authentication solutions based on leading edge information technologies
About BIO-key International, Inc. (www.bio-key.com)
BIO-key is revolutionizing authentication with our biometric solutions enabling convenient and secure access to information and securing high-stakes transactions. We offer alternatives to passwords, PINs tokens and cards to make it easy for enterprises and consumers to secure their devices as well as information in the cloud. Our premium finger scanning devices, including SideSwipe, SideTouch, EcoID and SidePass - FreePass (coming soon) offer market-leading quality, performance and price. Now anyone can BIO-key their world!
BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, market acceptance of biometric solutions generally and our specific offerings, our ability to expand into the Asian market, the impact on our business of the recent financial crisis in the global capital markets, and negative global economic trends, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2016 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made.
Investor & Media Contacts
David Collins, William Jones, Tanya Kamatu
Catalyst Global
212-924-9800
bkyi@catalyst-ir.com
Twitter : BIO-keyIR
19/06/2017 Dissemination of a Financial Press Release, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
Media archive at www.todayir.com
Wick(w50)
Recent BKYI News
- BIO-key Expands Deployment with Province of British Columbia, Adds 10,000 Biometric Users for Sign-on and Physical Access Control • GlobeNewswire Inc. • 09/23/2024 12:28:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 08:45:26 PM
- BIO-key International Enters into $1.9 Million Warrant Inducement • GlobeNewswire Inc. • 09/12/2024 05:18:35 PM
- Leading Government Defense Ministry Awards BIO-key $500K In Follow-On Orders for Biometric User Authentication • GlobeNewswire Inc. • 09/10/2024 12:27:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 08:34:27 PM
- Identity and Access Management Software Provider BIO-key to Participate at H.C. Wainwright Investment Conf. Sept. 9th to 10th • GlobeNewswire Inc. • 08/22/2024 05:10:00 PM
- BIO-key’s PortalGuard Identity and Access Management Solution and Identity-Bound Biometrics Are Now Available on the Amazon Web Services (AWS) Marketplace • GlobeNewswire Inc. • 08/15/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 09:00:34 PM
- BIO-key Reports Reduced Net Loss and Cash Used in Operations on Lower Q2’24 Revenues; Hosts Investor Call Thu. Aug. 15th at 10am ET • GlobeNewswire Inc. • 08/14/2024 08:30:00 PM
- Identity and Access Management Solutions Provider BIO-key Hosts Q2 Investor Call Thursday, August 15th at 10am ET • GlobeNewswire Inc. • 08/12/2024 02:35:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 10:12:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 10:06:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 09:52:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 09:46:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 09:40:42 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 08/02/2024 09:28:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 09:03:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 08:57:36 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/10/2024 08:30:50 PM
- Williamsburg, VA Advances Zero Trust Initiative for City Infrastructure and Data with BIO-key Identity-Bound Biometrics • GlobeNewswire Inc. • 07/08/2024 12:29:00 PM
- BIO-key Secures Los Angeles LGBT Center's IT Systems with Seamless Badge-Tap Authentication Solution • GlobeNewswire Inc. • 06/25/2024 12:29:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:17:51 PM
- Identity and Access Management Software Provider BIO-key Reports Q1’24 Revenue of $2.2M and Positive Operating Cash Flow; Hosts Investor Call Tuesday, 10am ET • GlobeNewswire Inc. • 06/17/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/14/2024 09:03:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 09:01:36 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM